These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33991784)

  • 1. Diffuse interstitial pneumonia-like/macrophage activation syndrome-like changes in patients with COVID-19 correlate with length of illness.
    Felix JC; Sheinin YM; Suster D; Ronen N; Ratiani M; Vanden Heuvel T; Winge E; Patton MD; Rau MJ; Ge L; Sun Y; Udhane SS; Langenheim JF; Rui H
    Ann Diagn Pathol; 2021 Aug; 53():151744. PubMed ID: 33991784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking the time course of pathological patterns of lung injury in severe COVID-19.
    Mauad T; Duarte-Neto AN; da Silva LFF; de Oliveira EP; de Brito JM; do Nascimento ECT; de Almeida Monteiro RA; Ferreira JC; de Carvalho CRR; do Nascimento Saldiva PH; Dolhnikoff M
    Respir Res; 2021 Jan; 22(1):32. PubMed ID: 33514373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China.
    Li Y; Wu J; Wang S; Li X; Zhou J; Huang B; Luo D; Cao Q; Chen Y; Chen S; Ma L; Peng L; Pan H; Travis WD; Nie X
    Histopathology; 2021 Mar; 78(4):542-555. PubMed ID: 32926596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19.
    Kritselis M; Yambayev I; Prilutskiy A; Shevtsov A; Vadlamudi C; Zheng H; Elsadwai M; Ma L; Aniskovich E; Kataria Y; Higgins S; Sarita-Reyes C; Zuo T; Zhao Q; Quillen K; Burks EJ
    Hum Pathol; 2021 Oct; 116():49-62. PubMed ID: 34273395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological changes in lungs of patients with fatal COVID 19 infection: A series of 15 cases.
    Medhi P; Dowerah S; Barman N; Singh M
    Indian J Pathol Microbiol; 2023; 66(4):834-838. PubMed ID: 38084542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of CDC Screening Guidelines and Autopsy Findings in Identifying Decedents Who Die of SARS-CoV-2 Infection.
    Konopka KE; Nguyen T; Hlavaty L; Rayes O; Schmidt CJ; Dahl J; Myers JL
    Am J Forensic Med Pathol; 2021 Jun; 42(2):118-120. PubMed ID: 33833197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
    J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autopsy-proven causes of death in lungs of patients immunocompromised by secondary interstitial pneumonia.
    Terrabuio Junior AA; Parra ER; Farhat C; Capelozzi VL
    Clinics (Sao Paulo); 2007 Feb; 62(1):69-76. PubMed ID: 17334552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases.
    Valdebenito S; Bessis S; Annane D; Lorin de la Grandmaison G; Cramer-Bordé E; Prideaux B; Eugenin EA; Bomsel M
    Front Immunol; 2021; 12():735922. PubMed ID: 34671353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE2 protein expression in lung tissues of severe COVID-19 infection.
    Gheware A; Ray A; Rana D; Bajpai P; Nambirajan A; Arulselvi S; Mathur P; Trikha A; Arava S; Das P; Mridha AR; Singh G; Soneja M; Nischal N; Lalwani S; Wig N; Sarkar C; Jain D
    Sci Rep; 2022 Mar; 12(1):4058. PubMed ID: 35260724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Features of the cell composition of inflammatory infiltrate in different phases of diffuse alveolar lung damage with COVID-19].
    Rodionov VE; Avdalyan AM; Konovalov DM; Boriskin NV; Tyurin IN; Protsenko DN; Zayratyants OV; Filipenko ML; Oskorbin IP; Koryukov MA
    Arkh Patol; 2022; 84(3):5-13. PubMed ID: 35639838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage.
    Beasley MB; Franks TJ; Galvin JR; Gochuico B; Travis WD
    Arch Pathol Lab Med; 2002 Sep; 126(9):1064-70. PubMed ID: 12204055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of BAX and BCL-2 expression in diffuse alveolar damage.
    Guinee D; Brambilla E; Fleming M; Hayashi T; Rahn M; Koss M; Ferrans V; Travis W
    Am J Pathol; 1997 Oct; 151(4):999-1007. PubMed ID: 9327733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.
    Konopka KE; Nguyen T; Jentzen JM; Rayes O; Schmidt CJ; Wilson AM; Farver CF; Myers JL
    Histopathology; 2020 Oct; 77(4):570-578. PubMed ID: 32542743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies.
    Doglioni C; Ravaglia C; Chilosi M; Rossi G; Dubini A; Pedica F; Piciucchi S; Vizzuso A; Stella F; Maitan S; Agnoletti V; Puglisi S; Poletti G; Sambri V; Pizzolo G; Bronte V; Wells AU; Poletti V
    Respiration; 2021; 100(6):488-498. PubMed ID: 33725700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.
    Sauter JL; Baine MK; Butnor KJ; Buonocore DJ; Chang JC; Jungbluth AA; Szabolcs MJ; Morjaria S; Mount SL; Rekhtman N; Selbs E; Sheng ZM; Xiao Y; Kleiner DE; Pittaluga S; Taubenberger JK; Rapkiewicz AV; Travis WD
    Histopathology; 2020 Dec; 77(6):915-925. PubMed ID: 32614086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two forms of diffuse alveolar damage in the lungs of patients with acute respiratory distress syndrome.
    Kang D; Nakayama T; Togashi M; Yamamoto M; Takahashi M; Kunugi S; Ishizaki M; Fukuda Y
    Hum Pathol; 2009 Nov; 40(11):1618-27. PubMed ID: 19647854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems.
    Barisione E; Grillo F; Ball L; Bianchi R; Grosso M; Morbini P; Pelosi P; Patroniti NA; De Lucia A; Orengo G; Gratarola A; Verda M; Cittadini G; Mastracci L; Fiocca R
    Virchows Arch; 2021 Mar; 478(3):471-485. PubMed ID: 32989525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Spectrum of Histopathologic Findings in Lungs of Patients With Fatal Coronavirus Disease 2019 (COVID-19) Infection.
    Roden AC; Bois MC; Johnson TF; Aubry MC; Alexander MP; Hagen CE; Lin PT; Quinton RA; Maleszewski JJ; Boland JM
    Arch Pathol Lab Med; 2021 Jan; 145(1):11-21. PubMed ID: 32821902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased number of pulmonary megakaryocytes in COVID-19 patients with diffuse alveolar damage: an autopsy study with clinical correlation and review of the literature.
    Valdivia-Mazeyra MF; Salas C; Nieves-Alonso JM; Martín-Fragueiro L; Bárcena C; Muñoz-Hernández P; Villar-Zarra K; Martín-López J; Ramasco-Rueda F; Fraga J; Jiménez-Heffernan JA
    Virchows Arch; 2021 Mar; 478(3):487-496. PubMed ID: 32915265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.